Upozornenie: Prezeranie týchto stránok je určené len pre návštevníkov nad 18 rokov!
Zásady ochrany osobných údajov.
Používaním tohto webu súhlasíte s uchovávaním cookies, ktoré slúžia na poskytovanie služieb, nastavenie reklám a analýzu návštevnosti. OK, súhlasím









A | B | C | D | E | F | G | H | CH | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9

Abetimus
 
Abetimus sodium
Clinical data
Trade namesRiquent
ATC code
Identifiers
CAS Number
PubChem SID
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
FormulaC1632H1944N610Na156O970P156S4
Molar mass54171.35 g·mol−1
 ☒NcheckY (what is this?)  (verify)

Abetimus (trade name Riquent) is an immunosuppressant.[1] It is a synthetic biological called a tolerogen. It is made of four double-stranded oligodeoxyribonucleotides that are attached to a carrier platform and are designed to block specific B-cell anti double stranded DNA antibodies.[2] It may also complex anti dsDNA antibodies together, therefore disabling them. This way abetimus was supposed to help treat systemic lupus erythematosus and specifically lupus nephritis.

It was developed by La Jolla Pharmaceutical, who applied for marketing authorisations in the mid-2000s, but the drug was never marketed in the US or in Europe.[3][4]

References

  1. ^ "Abetimus: Abetimus sodium, LJP 394". BioDrugs. 17 (3). Springer Nature Switzerland AG: 212–5. 2003. doi:10.2165/00063030-200317030-00009. PMID 12749759. S2CID 19896886.
  2. ^ Wallace DJ (January 2001). "Clinical and pharmacological experience with LJP-394". Expert Opinion on Investigational Drugs. 10 (1). Informa: 111–7. doi:10.1517/13543784.10.1.111. PMID 11116284. S2CID 43518002.
  3. ^ "Riquent Approval Status". Drugs.com. Retrieved 7 January 2017.
  4. ^ "Riquent". European Medicines Agency. Retrieved 7 January 2017.
Zdroj:https://en.wikipedia.org?pojem=Abetimus
>Text je dostupný pod licencí Creative Commons Uveďte autora – Zachovejte licenci, případně za dalších podmínek. Podrobnosti naleznete na stránce Podmínky užití.

čítajte viac o Abetimus


čítajte viac na tomto odkaze: Abetimus



Hladanie1.

File:Abetimus.svg
Drug nomenclature#Trade names
Anatomical Therapeutic Chemical Classification System
ATC code L04
CAS Registry Number
PubChem#SID
ChemSpider
Unique Ingredient Identifier
KEGG
Chemical formula
Molar mass
Wikipedia:WikiProject Chemicals/Chembox validation
Immunosuppressant
Tolerogen
Oligodeoxyribonucleotide
B-cell
DNA
Systemic lupus erythematosus
Lupus nephritis
Doi (identifier)
PMID (identifier)
S2CID (identifier)
Doi (identifier)
PMID (identifier)
S2CID (identifier)
Drugs.com
European Medicines Agency
Template:Immunosuppressants
Template talk:Immunosuppressants
Special:EditPage/Template:Immunosuppressants
Immunosuppressive drug
Immunosuppression
ATC code L04
Antimetabolite
Purine synthesis inhibitor
Azathioprine
Mycophenolic acid
Dihydroorotate dehydrogenase
Leflunomide
Teriflunomide
Antifolate
Methotrexate
Macrolide
Interleukin 2
FKBP
Cyclophilin
Calcineurin
Ciclosporin
Pimecrolimus
Tacrolimus
Voclosporin
Gusperimus
Immunomodulatory imide drug
Lenalidomide
Pomalidomide
Thalidomide
PDE4 inhibitor
Apremilast
Interleukin 1 receptor antagonist
Anakinra
MTOR
Everolimus
Ridaforolimus
Sirolimus
Temsirolimus
Umirolimus
Zotarolimus
Antibody
Monoclonal antibody
Complement component 5
Eculizumab
TNF inhibitor
Adalimumab
Afelimomab
Certolizumab pegol
Golimumab
Infliximab
Nerelimomab
Interleukin
Anakinra
Basiliximab
Bimekizumab
Briakinumab
Brodalumab
Canakinumab
Daclizumab
Guselkumab
Ixekizumab
Olokizumab
Rilonacept
Risankizumab
Sarilumab
Satralizumab
Secukinumab
Siltuximab
Sirukumab
Spesolimab
Tildrakizumab
Tocilizumab
Ustekinumab
Interleukin 5
Mepolizumab
Immunoglobulin E
Omalizumab
Interferon
Faralimomab
Interleukin 6
Elsilimomab
Interleukin 12
Interleukin 23
Lebrikizumab
Ustekinumab
Interleukin 17
Secukinumab
CD3 (immunology)
Muromonab-CD3
Otelixizumab
Teplizumab
Visilizumab
CD4
Clenoliximab
Keliximab
Zanolimumab
CD11a
Efalizumab
CD18
Erlizumab
CD20
Obinutuzumab
Ocrelizumab
Pascolizumab
Rituximab
Ublituximab
CD23
Gomiliximab
Lumiliximab
CD40 (protein)
Teneliximab
Toralizumab
L-selectin
Aselizumab
CD80
Galiximab
Basigin
Gavilimomab
CD154
Frexalimab
Ruplizumab
Belimumab
Chloramphenicol acetyltransferase
Bertilimumab
Lerdelimumab
Metelimumab
Integrin
Natalizumab
Vedolizumab
Interleukin-6 receptor
Tocilizumab
Lymphocyte function-associated antigen 1
Odulimomab
IL-2 receptor
Basiliximab
Daclizumab
Inolimomab
T cell
Zolimomab aritox
Alemtuzumab
Anifrolumab
Atorolimumab
Cedelizumab
Emapalumab
Fontolizumab
Inebilizumab
Maslimomab
Morolimumab
Ofatumumab
Pexelizumab
Reslizumab
Rovelizumab
Siplizumab
Talizumab
Telimomab aritox
Teprotumumab
Vapaliximab
Vepalimomab
Polyclonal antibodies
Anti-thymocyte globulin
Anti-lymphocyte globulin
Fusion protein
CTLA-4
Abatacept
Belatacept
TNF inhibitor
Etanercept
Aflibercept
Alefacept
Rilonacept
Avacopan
Baricitinib
Bimekizumab
Blisibimod
Briakinumab
Brodalumab
Canakinumab
Crovalimab
Danicopan
Darvadstrocel
Deucravacitinib
Deuruxolitinib
Dimethyl fumarate
Diroximel fumarate
Efgartigimod alfa
Efgartigimod alfa/hyaluronidase
Etrasimod
Filgotinib
Fingolimod
Guselkumab
Iptacopan
Ixekizumab
Olokizumab
Ozanimod
Peficitinib
Pegcetacoplan
Pirfenidone
Ponesimod
Ravulizumab
Risankizumab
Ritlecitinib
Rozanolixizumab
Sarilumab
Satralizumab
Siltuximab
Siponimod
Sirukumab
Spesolimab
Sutimlimab
Tildrakizumab
Tofacitinib
Upadacitinib
File:Cisplatin-3D-vdW.png
Antineoplastic
Immunomodulator
Pharmaceutical drug
Wikipedia:Stub
Template:Antineoplastic-drug-stub
Template talk:Antineoplastic-drug-stub
Special:EditPage/Template:Antineoplastic-drug-stub
Abetimus
Abetimus
Main Page
Wikipedia:Contents
Portal:Current events
Special:Random
Wikipedia:About
Wikipedia:Contact us
Special:FundraiserRedirector?utm source=donate&utm medium=sidebar&utm campaign=C13 en.wikipedia.org&uselang=en
Help:Contents
Help:Introduction
Wikipedia:Community portal
Special:RecentChanges
Wikipedia:File upload wizard
Main Page
Special:Search
Help:Introduction
Special:MyContributions
Special:MyTalk
آبتیموس
Abetimus
Abetimus
Special:EntityPage/Q4667244#sitelinks-wikipedia
Abetimus
Talk:Abetimus
Abetimus
Abetimus
Special:WhatLinksHere/Abetimus
Special:RecentChangesLinked/Abetimus
Wikipedia:File Upload Wizard
Special:SpecialPages
Special:EntityPage/Q4667244
Abetimus
Abetimus
Main Page
Wikipedia:Contents
Portal:Current events
Special:Random
Wikipedia:About
Wikipedia:Contact us
Special:FundraiserRedirector?utm source=donate&utm medium=sidebar&utm campaign=C13 en.wikipedia.org&uselang=en
Help:Contents
Help:Introduction
Wikipedia:Community portal
Special:RecentChanges
Wikipedia:File upload wizard
Main Page
Special:Search
Help:Introduction
Special:MyContributions
Special:MyTalk
آبتیموس
Abetimus
Abetimus
Special:EntityPage/Q4667244#sitelinks-wikipedia
Abetimus
Talk:Abetimus
Abetimus
Abetimus
Special:WhatLinksHere/Abetimus
Special:RecentChangesLinked/Abetimus
Wikipedia:File Upload Wizard
Special:SpecialPages
Special:EntityPage/Q4667244
Abetimus
Abetimus
Main Page
Wikipedia:Contents
Portal:Current events
Special:Random
Wikipedia:About
Wikipedia:Contact us
Updating...x




Text je dostupný za podmienok Creative Commons Attribution/Share-Alike License 3.0 Unported; prípadne za ďalších podmienok.
Podrobnejšie informácie nájdete na stránke Podmienky použitia.